Table IV.
Independent prognostic value of TLX1 in diffuse and intestinal gastric cancer.
| Variable | Diffuse gastric cancer
|
Intestinal gastric cancer
|
||
|---|---|---|---|---|
| HR (95% CI) | P-value | HR (95% CI) | P-value | |
| TLX1 (negative vs. positive) | Variable eliminated | 0.547 (0.321, 0.9325) | 0.027 | |
| Sex (male vs. female) | Variable eliminated | 1.924 (0.964, 3.840) | 0.064 | |
| Age | 1.023 (1.003, 1.042) | 0.020 | 1.069 (1.032, 1.107) | <0.001 |
| Stage | ||||
| Stage III vs. I/II | 2.190 (1.041, 4.610) | 0.039 | Variable eliminated | |
| Stage IV vs. I/II | 12.976 (6.214, 27.099) | <0.001 | Variable eliminated | |
| T (3 and 4 vs. 1 and 2) | Variable eliminated | 3.194 (1.871, 5.453) | <0.001 | |
| N (positive vs. negative) | Variable eliminated | 1.645 (1.213, 2.231) | 0.001 | |
| M (positive vs. negative) | Variable eliminated | Variable eliminated | ||
| Overall Cox model | <0.001 | |||
Variable eliminated, variables that were not statistically significant were eliminated in the model. Overall Cox model, the model including all variables that were not eliminated. CI, confidence interval; HR, hazard rate; TLX1, T-cell leukemia homeobox 1.